(HURN) Huron Consulting - NASDAQ
Sector: Industrials | Industry: Consulting Services | Exchange: NASDAQ (USA) | Market Cap: 1.725m USD | Total Return: -20.9% in 12m
Avg Turnover: 22.9M
EPS Trend: 99.2%
Qual. Beats: 3
Rev. Trend: 99.2%
Qual. Beats: 3
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Huron Consulting Group Inc. (HURN) is a global professional services firm headquartered in Chicago, operating primarily through Healthcare, Education, and Commercial segments. The company provides a broad range of operational and financial consulting, including revenue cycle management, organizational transformation, and strategy and innovation services.
The firm employs a diversified business model that integrates traditional management consulting with technology-driven solutions, such as enterprise resource planning (ERP) and artificial intelligence implementation. This hybrid approach is common in the Research & Consulting Services sector to create recurring revenue streams through managed services and software-as-a-service (SaaS) products.
Huron specializes in highly regulated industries, offering specific expertise in research administration and compliance for higher education and healthcare institutions. For a deeper look into these segment-specific growth drivers, consider reviewing the historical performance metrics on ValueRay.
- Healthcare segment demand driven by hospital margin pressure and regulatory complexity
- Expansion of digital transformation services through AI and data analytics integration
- Enrollment trends and research funding cycles impacting higher education consulting revenue
- Ability to attract and retain specialized consultants affects operating margin stability
- Macroeconomic conditions influencing commercial restructuring and capital advisory deal flow volume
| Net Income: 103.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -6.85 > 1.0 |
| NWC/Revenue: 16.26% < 20% (prev 14.97%; Δ 1.29% < -1%) |
| CFO/TA 0.09 > 3% & CFO 138.1m > Net Income 103.8m |
| Net Debt (893.7m) to EBITDA (227.5m): 3.93 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.4m) vs 12m ago -5.79% < -2% |
| Gross Margin: 30.56% > 18% (prev 32.18%; Δ -1.62% > 0.5%) |
| Asset Turnover: 117.7% > 50% (prev 111.9%; Δ 5.79% > 0%) |
| Interest Coverage Ratio: 5.15 > 6 (EBIT TTM 192.9m / Interest Expense TTM 37.4m) |
| A: 0.18 (Total Current Assets 514.7m - Total Current Liabilities 232.2m) / Total Assets 1.59b |
| B: 0.38 (Retained Earnings 608.3m / Total Assets 1.59b) |
| C: 0.13 (EBIT TTM 192.9m / Avg Total Assets 1.48b) |
| D: 0.33 (Book Value of Equity 397.4m / Total Liabilities 1.19b) |
| Altman-Z'' = 3.64 = AA |
| DSRI: 1.02 (Receivables 453.0m/388.4m, Revenue 1.74b/1.53b) |
| GMI: 1.05 (GM 32.18% / 30.56%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.14 (Revenue 1.74b / 1.53b) |
| TATA: -0.02 (NI 103.8m - CFO 138.1m) / TA 1.59b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of June 16, 2026, the stock is trading at USD 107.11 with a total of 187,927 shares traded.
Over the past week, the price has changed by -2.32%,
over one month by +1.55%,
over three months by -15.48% and
over the past year by -20.90%.
Huron Consulting has received a consensus analysts rating of 4.80. Therefore, it is recommended to buy HURN.
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 184.3 | 72% |
P/E Trailing = 18.1932
P/E Forward = 12.837
P/S = 1.0085
P/B = 4.4641
P/EG = 1.5199
Revenue TTM = 1.74b USD
EBIT TTM = 192.9m USD
EBITDA TTM = 227.5m USD
Long Term Debt = 834.7m USD (from longTermDebt, last quarter)
Short Term Debt = 31.2m USD (from shortTermDebt, last quarter)
Debt = 920.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 32.7m
Net Debt = 893.7m USD (calculated: Debt 920.1m - CCE 26.5m)
Enterprise Value = 2.62b USD (1.73b + Debt 920.1m - CCE 26.5m)
Interest Coverage Ratio = 5.15 (Ebit TTM 192.9m / Interest Expense TTM 37.4m)
EV/FCF = 21.16x (Enterprise Value 2.62b / FCF TTM 123.8m)
FCF Yield = 4.73% (FCF TTM 123.8m / Enterprise Value 2.62b)
FCF Margin = 7.12% (FCF TTM 123.8m / Revenue TTM 1.74b)
Net Margin = 5.97% (Net Income TTM 103.8m / Revenue TTM 1.74b)
Gross Margin = 30.56% ((Revenue TTM 1.74b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 27.85% (prev 30.98%)
Tobins Q-Ratio = 1.65 (Enterprise Value 2.62b / Total Assets 1.59b)
Interest Expense / Debt = 4.07% (Interest Expense 37.4m / Debt 920.1m)
Taxrate = 26.26% (36.9m / 140.7m)
NOPAT = 142.3m (EBIT 192.9m * (1 - 26.26%))
Current Ratio = 2.22 (Total Current Assets 514.7m / Total Current Liabilities 232.2m)
Debt / Equity = 2.32 (Debt 920.1m / totalStockholderEquity, last quarter 397.4m)
Debt / EBITDA = 3.93 (Net Debt 893.7m / EBITDA 227.5m)
Debt / FCF = 7.22 (Net Debt 893.7m / FCF TTM 123.8m)
Total Stockholder Equity = 475.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.03% (Net Income 103.8m / Total Assets 1.59b)
RoE = 21.83% (Net Income TTM 103.8m / Total Stockholder Equity 475.2m)
RoCE = 14.73% (EBIT 192.9m / Capital Employed (Equity 475.2m + L.T.Debt 834.7m))
RoIC = 10.45% (NOPAT 142.3m / Invested Capital 1.36b)
WACC = 5.37% (E(1.73b)/V(2.65b) * Re(6.64%) + D(920.1m)/V(2.65b) * Rd(4.07%) * (1-Tc(0.26)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.44 | Cagr: -4.68%
[DCF] Terminal Value 73.10% ; FCFF base≈154.1m ; Y1≈135.1m ; Y5≈109.2m
[DCF] Fair Price = 52.98 (EV 1.75b - Net Debt 893.7m = Equity 858.9m / Shares 16.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 99.21 | EPS CAGR: 25.47% | SUE: 0.89 | # QB: 3
Revenue Correlation: 99.20 | Revenue CAGR: 11.19% | SUE: 1.04 | # QB: 3
EPS current Quarter (2026-06-30): EPS=2.17 | Chg30d=-0.64% | Revisions=+0% | Analysts=5
EPS next Quarter (2026-09-30): EPS=2.43 | Chg30d=-0.33% | Revisions=-11% | Analysts=5
EPS current Year (2026-12-31): EPS=8.84 | Chg30d=-0.07% | Revisions=+11% | GrowthEPS=+12.8% | GrowthRev=+9.9%
EPS next Year (2027-12-31): EPS=10.22 | Chg30d=+0.20% | Revisions=+33% | GrowthEPS=+15.6% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: +33%